Why Trading Biotech and Pharma Stocks is a Mistake!

Hedge Funds and Investment Banks have literal teams of PhD Biochemists as Research Analysts and Portfolio Managers that have studied chemical compounds for years (trust me I know some of these individuals — you do NOT want to compete with them in a zero sum game that is the Stock Market).

Pharma and Biotech Stocks have Current Drug Portfolios and Pipeline Drugs that are going through phases of approval i.e., ‘P1’, ‘P2’, and ‘P3’ approvals with FDA.

Read More